Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer

Silvia Achilli , Nathalie Berthet * and Olivier Renaudet *
Univ. Grenoble Alpes, CNRS, DCM UMR 5250, F-38000, Grenoble, France. E-mail: nathalie.berthet@univ-grenoble-alpes.fr; olivier.renaudet@univ-grenoble-alpes.fr

Received 13th July 2021 , Accepted 13th July 2021

First published on 22nd July 2021


Abstract

Correction for ‘Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer’ by Silvia Achilli et al., RSC Chem. Biol., 2021, 2, 713–724. DOI: 10.1039/d1cb00007a.


The authors regret mistakes in the structures depicted in Table 1, entry A and Table 2, entry B. The correct version of both tables are shown below. The conclusions of the paper have not been affected.
Table 1 Examples of ARMs against cancer cells
Entry Tumor target ARM valency ABM TBM ARM structure
A41 uPAR Mono DNP uPAR inhibitor image file: d1cb90021h-u1.tif
B46 VEGF/osteopotin Mono DNP anti-VEGF and anti-osteopontin aptamer image file: d1cb90021h-u2.tif
C51 Folate receptor Mono Fc-binding cyclic peptide Folic acid image file: d1cb90021h-u3.tif
D55 PSMA Mono DNP Glutamate urea image file: d1cb90021h-u4.tif
E56 αvβ3 integrins Multi L-Rha cRGD image file: d1cb90021h-u5.tif


Table 2 Example of ARMs using unspecific targeting of the cancer cell membrane with lipid anchor
Entry Tumor target ARM valency ABM TBM ARM structure
A12 uPAR Multi L-Rha CholA anchor image file: d1cb90021h-u6.tif
B65 VEGF/osteopotin Multi DNP Di-alkyl anchor image file: d1cb90021h-u7.tif


The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2021
Click here to see how this site uses Cookies. View our privacy policy here.